ArticleCancer management and research2022

Treatment Responses, Toxicity, and Survival in Patients with Classical Hodgkin Lymphoma Aged ≥50 Years: A Single-Center Experience Over Two Decades.

Simay Çokgezer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.